J.P.
Biogen Inc (NASDAQ:BIIB) has decided to promote from within, opting to transition Chief Commercial Officer Michel Vounatsos into the role of CEO, a …
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Biogen Inc (NASDAQ:BIIB) have recently given biotech investors a lot of food for thought with new clinical …
As we reviewed our portfolio this quarter, we found ourselves in an unusual position…with nothing to do. We, thus, heeded Warren Buffett’s wise …
Analysts are out with varied research reports on three of the biotech sector’s players: Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Biogen Inc (NASDAQ:BIIB), and Eagle Pharmaceuticals …
In a research report released today, H.C.
Anavex Life Sciences Corp. (NASDAQ:AVXL) announced that its oral pipeline drug candidate 2-73, developed to potentially modify Alzheimer’s disease rather than just temporarily …
Biogen Inc (NASDAQ:BIIB) is riding the tide of good news after a recent publication has indicated the mechanism in the biotech giant’s pipeline …
Last week, representatives from some of the largest healthcare companies in the world flocked to New York City to participate in Morgan Stanley’s …
At last week’s European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conference, Biogen Inc (NASDAQ:BIIB) provided “further clarity” on the “unexpected …
